Distribuzione geografica
Continente #
NA - Nord America 578
EU - Europa 236
AS - Asia 70
SA - Sud America 5
AF - Africa 3
Totale 892
Nazione #
US - Stati Uniti d'America 572
ES - Italia 75
IT - Italia 57
SE - Svezia 35
KR - Corea 22
DE - Germania 15
JP - Giappone 13
VN - Vietnam 12
CN - Cina 8
GB - Regno Unito 8
PL - Polonia 7
FR - Francia 6
HK - Hong Kong 6
IE - Irlanda 5
IN - India 5
RU - Federazione Russa 5
GR - Grecia 4
NL - Olanda 4
CA - Canada 3
CO - Colombia 3
CZ - Repubblica Ceca 3
MX - Messico 3
CH - Svizzera 2
DK - Danimarca 2
LV - Lettonia 2
MY - Malesia 2
RS - Serbia 2
BE - Belgio 1
BR - Brasile 1
CL - Cile 1
EG - Egitto 1
LT - Lituania 1
MA - Marocco 1
PT - Portogallo 1
SG - Singapore 1
SK - Slovacchia (Repubblica Slovacca) 1
TR - Turchia 1
ZA - Sudafrica 1
Totale 892
Città #
Zaragoza 69
Santa Cruz 54
Ashburn 52
Houston 44
Fairfield 36
Stockholm 34
Buffalo 27
Ann Arbor 23
Ferrara 23
Seattle 21
Chicago 19
Boardman 18
Des Moines 15
Woodbridge 15
Dong Ket 12
Los Angeles 12
San Diego 12
Seongnam 12
Wilmington 10
Cambridge 8
Dallas 8
Seoul 8
Las Vegas 7
Central 6
Longmont 6
Rome 6
Warsaw 6
Dublin 5
Ferrara di Monte Baldo 5
New York 5
Providence 5
Chengdu 4
Denver 4
Provo 4
Boulder 3
Bremen 3
Brooklyn 3
Córdoba 3
Lake Forest 3
Lucknow 3
Munich 3
Tourcoing 3
Abano Terme 2
Adelfia 2
Athens 2
Avon 2
Barranquilla 2
Belgrade 2
Bengaluru 2
Brighton 2
Castello Di Fiemme 2
Chiba 2
Chilpancingo 2
Chiyoda-ku 2
Columbus 2
Crugers 2
Dulles 2
Fleming Island 2
Genoa 2
Henderson 2
Herndon 2
Hillsboro 2
Imola 2
Kirkland 2
Lyon 2
Memphis 2
Nikaia 2
Odense 2
Portland 2
Rosendaal 2
Saint Paul 2
Saint Petersburg 2
San Jose 2
Shibuya 2
Shu 2
Toronto 2
Torpoint 2
Zurich 2
Beijing 1
Bologna 1
Brasília 1
Breda 1
Brockport 1
Cairo 1
Camponogara 1
Cedar Knolls 1
Clearwater 1
Edinburgh 1
Edison 1
Frankfurt am Main 1
Huntsville 1
Islington 1
Istanbul 1
Jacksonville 1
Karlsruhe 1
Kobe 1
Lombard 1
London 1
Madrid 1
McHenry 1
Totale 713
Nome #
Control of pituitary adenoma cell proliferation by somatostatin analogs, dopamine agonists and novel chimeric compounds, file e309ade0-26af-3969-e053-3a05fe0a2c94 193
Proposal for a novel management of indeterminate thyroid nodules on the basis of cytopathological subclasses, file e309ade1-306b-3969-e053-3a05fe0a2c94 113
Corticotropin releasing hormone: a diagnostic marker for behavioral and reproductive disorders?, file e309ade0-246f-3969-e053-3a05fe0a2c94 76
mTOR, AKT, p70S6K and ERK1/2 levels predict sensitivity to mTOR and PI3K/mTOR inhibitors in human bronchial carcinoids, file e309ade4-7d55-3969-e053-3a05fe0a2c94 74
HHV-6A in vitro infection of thyrocytes and T cells alters the expression of miRNA associated to autoimmune thyroiditis, file e309ade1-059c-3969-e053-3a05fe0a2c94 48
Relevance of BRAF(V600E) Mutation Testing Versus RAS Point Mutations and RET/PTC Rearrangements Evaluation in the Diagnosis of Thyroid Cancer, file e309ade0-90ac-3969-e053-3a05fe0a2c94 47
Everolimus as a new potential antiproliferative agent in aggressive human bronchial carcinoids, file e309ade0-3375-3969-e053-3a05fe0a2c94 46
Evaluation of the Role of BRAFV600E Somatic Mutation on Papillary Thyroid Cancer Disease Persistence: A Prospective Study, file e309ade2-160f-3969-e053-3a05fe0a2c94 30
Relevance of BRAF(V600E) Mutation Testing Versus RAS Point Mutations and RET/PTC Rearrangements Evaluation in the Diagnosis of Thyroid Cancer, file e309ade2-dd73-3969-e053-3a05fe0a2c94 30
Early onset acromegaly associated with a novel deletion in CDKN1B 5'UTR region, file e309ade0-8a6a-3969-e053-3a05fe0a2c94 28
Anterior pituitary function may predict functional and cognitive outcome in patients with traumatic brain injury undergoing rehabilitation., file e309ade1-47f6-3969-e053-3a05fe0a2c94 22
MicroRNAs in the pituitary, file e309ade4-7fd2-3969-e053-3a05fe0a2c94 20
Residual pituitary function after brain injury-induced hypopituitarism: a prospective 12-month study., file e309ade1-45d4-3969-e053-3a05fe0a2c94 14
Should aip gene screening be recommended in family members of FIPA patients with R16H variant?, file e309ade0-37b1-3969-e053-3a05fe0a2c94 9
Igf-I influences everolimus activity in medullary thyroid carcinoma, file e309ade0-8d20-3969-e053-3a05fe0a2c94 9
Cyclooxygenase-2 inhibitors prevent the development of chemoresistance phenotype in a breast cancer cell line by inhibiting glycoprotein p-170 expression., file e309ade0-26b3-3969-e053-3a05fe0a2c94 7
Androgen influences transforming growth factor-β1 gene expression in human adrenocortical cells, file e309ade0-2d16-3969-e053-3a05fe0a2c94 7
N-carbamidoyl-4-((3-ethyl-2,4,4-trimethylcyclohexyl)methyl)benzamide enhances staurosporine cytotoxic effects likely inhibiting the protective action of Magmas toward cell apoptosis, file e309ade0-405c-3969-e053-3a05fe0a2c94 7
Evidence that enhancement of cholinergic tone increases basal plasma levels of calcitonin gene-related peptide in normal man, file e309ade0-21f1-3969-e053-3a05fe0a2c94 6
Time-dependent effect of isradipine on the nocturnal hypertension in chronic renal failure, file e309ade0-2da3-3969-e053-3a05fe0a2c94 6
Targeting protein kinase C by Enzastaurin restrains proliferation and secretion in human pancreatic endocrine tumors, file e309ade1-4e23-3969-e053-3a05fe0a2c94 6
Effect of deltorphin on pituitary-adrenal response to insulin-induced hypoglycemia and ovine corticotropin-releasing hormone in healthy man, file e309ade0-21f9-3969-e053-3a05fe0a2c94 5
Atrial strain is the main determinant of release of atrial natriuretic peptide, file e309ade0-2201-3969-e053-3a05fe0a2c94 5
Somatostatin receptor subtypes 2 and 5 differentially affect proliferation in vitro of the human medullary thyroid carcinoma cell line, TT, file e309ade0-2ee1-3969-e053-3a05fe0a2c94 5
Effect of Everolimus on Cell Viability in Nonfunctioning Pituitary Adenomas, file e309ade0-3d3a-3969-e053-3a05fe0a2c94 5
Increase in Peripheral CD3-CD56brightCD16- Natural Killer Cells in Hashimoto's Thyroiditis Associated with HHV-6 Infection, file e309ade0-9db7-3969-e053-3a05fe0a2c94 5
Effect of dermorphin on behavior and hippocampal electrical activity in rabbits, file e309ade0-21f5-3969-e053-3a05fe0a2c94 4
Circadian rhythms of atrial natriuretic peptide, renin, aldosterone, cortisol, blood pressure and heart rate in normal and hypertensive subjects, file e309ade0-2203-3969-e053-3a05fe0a2c94 4
Chromogranin A as a marker of neuroendocrine neoplasia: an Italian Multicenter Study., file e309ade0-26b1-3969-e053-3a05fe0a2c94 4
Somatostatin and thyroid, file e309ade0-2d18-3969-e053-3a05fe0a2c94 4
An in vivo OctreoScan-negative adrenal pheochromocytoma expresses somatostatin receptors and responds to somatostatin analogs treatment in vitro, file e309ade0-2ee2-3969-e053-3a05fe0a2c94 4
Predictors of Pituitary Dysfunction in Patients Surviving Ischemic Stroke, file e309ade0-3376-3969-e053-3a05fe0a2c94 4
Role of complex Cyclin D1/Cdk4 in somatostatin subtype 2 receptor-mediated inhibition of cell proliferation of a medullary thyroid carcinoma cell line in vitro., file e309ade0-3aa7-3969-e053-3a05fe0a2c94 4
BRAFmutation positive papillary thyroid carcinoma is less advanced when Hashimoto's thyroiditis lymphocytic infiltration is present, file e309ade0-413b-3969-e053-3a05fe0a2c94 4
Deletion of exons 1-3 of the MEN1 gene in a large Italian family causes the loss of menin expression, file e309ade0-4db6-3969-e053-3a05fe0a2c94 4
miR-26a Plays an Important Role in Cell Cycle Regulation in ACTH-Secreting Pituitary Adenomas by Modulating Protein Kinase C , file e309ade0-b7ea-3969-e053-3a05fe0a2c94 4
Circadian rhythms of atrial natriuretic peptide and blood pressure are consistently blunted in chronic renal failure, file e309ade0-21e4-3969-e053-3a05fe0a2c94 3
Circadian rhythm of calcitonin gene-related peptide in uncomplicated essential hypertension, file e309ade0-21f7-3969-e053-3a05fe0a2c94 3
Consistent changes in the circadian rhythms of blood pressure and atrial natriuretic peptide in congestive heart failure, file e309ade0-21fc-3969-e053-3a05fe0a2c94 3
Proteasomes and RARS modulate AIMP1/EMAP II secretion in human cancer cell lines., file e309ade0-26b0-3969-e053-3a05fe0a2c94 3
Systemic illness, file e309ade0-282d-3969-e053-3a05fe0a2c94 3
Somatostatin receptor subtype 1 selective activation in human growth hormone- and prolactin-secreting pituitary adenomas: effects on cell viability, growth hormone and prolactin secretion., file e309ade0-2d17-3969-e053-3a05fe0a2c94 3
Therapeutic concentrations of mitotane (o,p'-DDD) inhibit thyrotroph cell viability and TSH expression and secretion in a mouse cell line model., file e309ade0-3373-3969-e053-3a05fe0a2c94 3
Growth hormone receptor blockade inhibits growth hormone-induced chemoresistance by restoring cytotoxic-induced apoptosis in breast cancer cells independently of estrogen receptor expression., file e309ade0-33b5-3969-e053-3a05fe0a2c94 3
HypoparaNet: A Database of Chronic Hypoparathyroidism Based on Expert Medical-Surgical Centers in Italy, file e309ade1-fac1-3969-e053-3a05fe0a2c94 3
Loss of nocturnal increase in plasma concentration of atrial natriuretic peptide in hypertensive chronic renal failure, file e309ade0-21f8-3969-e053-3a05fe0a2c94 2
Identification of differentially expressed microRNAs by microarray: a possible role for microRNA genes in pituitary adenomas., file e309ade0-2479-3969-e053-3a05fe0a2c94 2
Pasireotide, a multiple somatostatin receptor subtypes ligand, reduces cell viability in non functioning pituitary adenomas by inhibiting Vascular Endothelial Growth Factor secretion., file e309ade0-249b-3969-e053-3a05fe0a2c94 2
In vitro testing of new somatostatin analogs on pituitary tumor cells, file e309ade0-27cc-3969-e053-3a05fe0a2c94 2
Evidence for androgen receptor gene expression and growth inhibitory effect of dihydrotestosterone on human adrenocortical cells., file e309ade0-2ee0-3969-e053-3a05fe0a2c94 2
Magmas, a Gene Newly Identified as Overexpressed in Human and Mouse ACTH-Secreting Pituitary Adenomas, Protects Pituitary Cells from Apoptotic Stimuli, file e309ade0-3372-3969-e053-3a05fe0a2c94 2
A novel germline CDKN1B mutation causing multiple endocrine tumors: clinical, genetic and functional characterization, file e309ade0-34f4-3969-e053-3a05fe0a2c94 2
Virologic and immunologic evidence supporting an association between HHV-6 and Hashimoto’s thyroiditis, file e309ade0-3a18-3969-e053-3a05fe0a2c94 2
BRAF V600E mutation analysis increases diagnostic accuracy for papillary thyroid carcinoma in fine needle aspiration biopsies., file e309ade0-3ca6-3969-e053-3a05fe0a2c94 2
Dopamine receptor subtype 2 and somatostatin receptor subtype 5 expression influences somatostatin analogs effects on human somatotroph pituitary adenomas in vitro, file e309ade1-47c5-3969-e053-3a05fe0a2c94 2
Predictive value of circulating insulin-like growth factor I levels in ischemic stroke outcome., file e309ade1-47fa-3969-e053-3a05fe0a2c94 2
Hypoparathyroidism and pseudohypoparathyroidism in pregnancy: an Italian retrospective observational study, file e309ade5-0614-3969-e053-3a05fe0a2c94 2
null, file e309ade0-302a-3969-e053-3a05fe0a2c94 1
Expression of functional KISS1 and KISS1R system is altered in human pituitary adenomas: evidence for apoptotic action of kisspeptin-10., file e309ade0-3423-3969-e053-3a05fe0a2c94 1
Mitotane enhances doxorubicin cytotoxic activity by inhibiting P-gp in human adrenocortical carcinoma cells, file e309ade0-4147-3969-e053-3a05fe0a2c94 1
mTOR, p70S6K, AKT and ERK1/2 levels predict sensitivity to mTOR and PI3K/mTOR inhibitors in human bronchial carcinoids, file e309ade0-4196-3969-e053-3a05fe0a2c94 1
Mitotane reduces human and mouse ACTH-secreting pituitary cell viability and function., file e309ade0-4571-3969-e053-3a05fe0a2c94 1
Rare diseases in clinical endocrinology: a taxonomic classification system., file e309ade0-b2d7-3969-e053-3a05fe0a2c94 1
MicroRNAs in the pituitary, file e309ade1-09c4-3969-e053-3a05fe0a2c94 1
Protein Kinase C Delta restrains growth in ACTH-secreting pituitary adenoma cells, file e309ade1-0db1-3969-e053-3a05fe0a2c94 1
Evaluation of the Role of BRAFV600E Somatic Mutation on Papillary Thyroid Cancer Disease Persistence: A Prospective Study, file e309ade2-d61a-3969-e053-3a05fe0a2c94 1
Totale 923
Categoria #
all - tutte 2433
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 5
Totale 2438

Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201923 0002 12 11 2365
2019/202048 5355 36 44 5332
2020/2021116 3423 1116 115 3122125
2021/2022240 1172332 2511 1313 16115325
2022/2023488 102356105 9737 4596 19000
Totale 923